Epigenetics in heart failure

Annals of the New York Academy of Sciences

Volumn 1188, Issue , 2010, Pages 159-164

  Papait, Roberto ^a   Condorelli, Gianluigi ^a,b,c  

^a IRCCS MULTIMEDICA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Heart; Histone acetylation; Histone methylation; Hypertrophy

Indexed keywords

HISTONE;

ACETYLATION; CONFERENCE PAPER; CPG ISLAND; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; PROTEIN METHYLATION; PROTEIN MODIFICATION; UPREGULATION;

EID: 77649102924     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05096.x     Document Type: Conference Paper

References (44)

1. Herron, T. J. & K. S. McDonald. 2002. Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ Res. 90: 1150-1152.
2. Olson, E. N., J. Backs & T. A. McKinsey. 2006. Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation. Novartis Found. Symp. 274: 3-12; discussion 13-19, 152-155,272-276.
3. 3. Misteli, T. 2007. Beyond the sequence: cellular organization of genome function. Cell 128: 787-800. (Pubitemid 46273571) (Pubitemid 46273571)
4. Nikitina, T. et al. 2007. Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. Mol Cell Biol 27: 864-877.
5. 5. Lachner, M. et al. 2001. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410: 116-120. (Pubitemid 32225847) (Pubitemid 32225847)
6. 6. Bannister, A. J. et al. 2001. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410: 120-124. (Pubitemid 32225848) (Pubitemid 32225848)
7. Cosgrove, M. S., J. D. Boeke & C. Wolberger. 2004. Regulated nucleosome mobility and the histone code. Nat. Struct. Mol. Biol. 11: 1037-1043.
8. Suzuki, M. M. & A. Bird. 2008. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 9: 465-476.
9. 9. Hendrich, B. & S. Tweedie. 2003. The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet. 19: 269-277. (Pubitemid 36507009) (Pubitemid 36507009)
10. Ng, H. H. et al. 1999. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet. 23: 58-61.
11. Clouaire, T. & I. Stancheva. 2008. Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin? Cell. Mol. Life Sci. 65: 1509-1522.
12. 12. Kangaspeska, S. et al. 2008. Transient cyclical methylation of promoter DNA. Nature 452: 112-115. (Pubitemid 351355094) (Pubitemid 351355094)
13. Metivier, R. et al. 2008. Cyclical DNA methylation of a transcriptionally active promoter. Nature 452: 45-50.
14. Jenuwein, T. & C. D. Allis. 2001. Translating the histone code. Science 293: 1074-1080.
15. 15. Grunstein, M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389: 349-352. (Pubitemid 27415209) (Pubitemid 27415209)
16. 16. Shogren-Knaak, M. et al. 2006. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311: 844-847. (Pubitemid 43228847) (Pubitemid 43228847)
17. Wang, X. & J. J. Hayes. 2008. Acetylation mimics within individual core histone tail domains indicate distinct roles in regulating the stability of higherorder chromatin structure. Mol. Cell. Biol. 28: 227-236.
18. 18. Matangkasombut, O. et al. 2000. Bromodomain factor 1 corresponds to a missing piece of yeast TFIID. Genes Dev. 14: 951-962. (Pubitemid 30253004)
19. Wolffe, A. P. 1996. Histone deacetylase: a regulator of transcription. Science 272: 371-372.
20. Haberland, M., R. L. Montgomery & E. N. Olson. 2009. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10: 32-42.
21. 21. Martin, C. & Y. Zhang. 2005. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell. Biol. 6: 838-849. (Pubitemid 41568733) (Pubitemid 41568733)
22. 22. Schneider, R. et al. 2004. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat. Cell Biol. 6: 73-77. (Pubitemid 38425733) (Pubitemid 38425733)
23. 23. Bernstein, B. E. et al. 2005. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120: 169-181. (Pubitemid 40174761) (Pubitemid 40174761)
24. Sims, R. J. et al. 2007. Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol. Cell. 28: 665-676.
25. Kouzarides, T. 2002. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12: 198-209.
26. 26. Klose, R. J. & Y. Zhang. 2007. Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 8: 307-318. (Pubitemid 46474659) (Pubitemid 46474659)
27. Agger, K. et al. 2008. The emerging functions of histone demethylases. Curr. Opin. Genet. Dev. 18: 159-168.
28. 28. Feinberg, A. P. 2007. Phenotypic plasticity and the epigenetics of human disease. Nature 447: 433-440. (Pubitemid 46816750) (Pubitemid 46816750)
29. Longo, V. D. & B. K. Kennedy. 2006. Sirtuins in aging and age-related disease. Cell 126: 257-268.
30. 30. Suzuki, A., R. Yamada & K. Yamamoto. 2007. Citrullination by peptidylarginine deiminase in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 1108: 323-339. (Pubitemid 47528745)
31. Migliore, L. & F. Coppede. 2008. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat. Res. 6: 36-47.
32. Kriaucionis, S. & A. Bird. 2003. DNA methylation and Rett syndrome. Hum. Mol. Genet. 12(Spec No 2): R221-R227.
33. Zhang, C. L. et al. 2002. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110: 479-488.
34. Trivedi, C. M. et al. 2007. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat. Med. 13: 324-331.
35. Chang, S. et al. 2004. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol. Cell Biol. 24: 8467-8476.
36. McKinsey, T. A., C. L. Zhang & E. N. Olson. 2000. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinasestimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl. Acad. Sci. USA 97: 14400-14405.
37. Grozinger, C. M. & S. L. Schreiber. 2000. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA 97: 7835-7840.
38. Antos, C. L. et al. 2003. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J. Biol Chem. 278: 28930-28937.
39. Gallo, P., et al. 2008. Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. Cardiovasc. Res. 80: 416-424.
40. Gupta, M. P. et al. 2008. HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity. J. Biol Chem. 283: 10135-10146.
41. Chen, X. et al. 2006. Expression of nitric oxide related enzymes in coronary heart disease. Basic Res. Cardiol. 101: 346-353.
42. Majumdar, G. et al. 2008. Epigenetic regulation of cardiac muscle-specific genes in H9c2 cells by Interleukin18 and histone deacetylase inhibitor m-carboxycinnamic acid bis-hydroxamide. Mol. Cell Biochem. 312: 47-60.
43. Bingham, A. J. et al. 2007. The repressor element 1silencing transcription factor regulates heart-specific gene expression using multiple chromatin-modifying complexes. Mol. Cell Biol. 27: 4082-4092.
44. Kaneda, R. et al. 2009. Genome-wide histone methylation profile for heart failure. Genes Cells 14: 69-77.